← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2002Last known activity
Feb 1, 2025
Timeline
1910s
- Jan 1, 1918
Ligue contre le cancer, France— Founded
Drugs by trial phase (18 distinct, 10 trials)
Phase 3 (8 own, 0 via acquisition)
Phase 2 (9 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
- Asthenia
- Carcinoma, Neuroendocrine
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Renal Cell
- Central Nervous System Neoplasms
- Diarrhea
- Glioblastoma
- Head and Neck Neoplasms
- Microsatellite Instability
- Neoplasms
- Neoplasms, Germ Cell and Embryonal
- Nervous System Neoplasms
- Osteosarcoma
- Ovarian Neoplasms
- Penile Neoplasms
- Skin Neoplasms
- Thyroid Neoplasms
Recent trials (10)
- NCT06807164CollaboratorPhase 2Feb 1, 2025
- NCT06524583CollaboratorPhase 2Oct 31, 2024
- NCT03012581CollaboratorPhase 2Jun 1, 2017
- NCT03012620CollaboratorPhase 2Jun 1, 2017
- NCT02323516CollaboratorPhase 2Dec 1, 2014
- NCT01884623CollaboratorPhase 3Jun 1, 2013
- NCT01043536CollaboratorPhase 1Sep 1, 2009
- NCT00470223CollaboratorPhase 3Mar 1, 2007
- NCT00273741CollaboratorPhase 3Jan 1, 2007
- NCT00198432CollaboratorPhase 2Mar 1, 2002
Details
- Founded
- Paris, FR Jan 1, 1918
- Last known activity
- Feb 1, 2025